End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
903.6 USD | 0.00% | 0.00% | 0.00% |
Jul. 08 | Health Care Flat Amid Deal Activity -- Health Care Roundup | DJ |
Jul. 08 | S&P 500, Nasdaq Extend Record Closing Runs | MT |
Chart calendar Eli Lilly and Company
Upcoming events on Eli Lilly and Company
Past events on Eli Lilly and Company
2024-06-21 03:45 pm | American Diabetes Association Scientific Symposium |
2024-06-10 04:00 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
2024-06-03 06:12 pm | American Society of Clinical Oncology Meeting - Abstract Number: LBA507 |
2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract Number: 8547 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 5589 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 11111 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 11068 |
2024-06-02 08:30 pm | American Society of Clinical Oncology Meeting |
2024-06-02 06:06 pm | American Society of Clinical Oncology Meeting - Abstract Number: 10022 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 1027 |
2024-06-01 06:00 pm | American Society of Clinical Oncology Meeting - Abstract Number: 3007 |
2024-06-01 04:12 pm | American Society of Clinical Oncology Meeting - Abstract Number: 5001 |
2024-06-01 04:00 pm | American Society of Clinical Oncology Meeting - Abstract Number: LBA1001 |
2024-06-01 02:39 pm | American Society of Clinical Oncology Meeting - Abstract Number: 8510 |
2024-06-01 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 3150 |
2024-05-14 | Détachement de |
2024-05-06 08:30 am | Annual General Meeting |
2024-04-30 10:00 am | Q1 2024 Earnings Call |
2024-04-30 06:45 am | Q1 2024 Earnings Release |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract Number: 3230 |
Past dividends on Eli Lilly and Company
2024-05-14 | Quarterly 1.3 USD |
2024-02-13 | Quarterly 1.3 USD |
2023-11-13 | Quarterly 1.13 USD |
2023-08-13 | Quarterly 1.13 USD |
2023-05-11 | Quarterly 1.13 USD |
2023-02-13 | Quarterly 1.13 USD |
2022-11-13 | Quarterly 0.98 USD |
2022-08-11 | Quarterly 0.98 USD |
2022-05-12 | Quarterly 0.98 USD |
2022-02-13 | Quarterly 0.98 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22 320 22 142 0.8% | 24 540 24 394 0.6% | 28 318 28 205 0.4% | 28 541 28 641 -0.35% | 34 124 33 585 1.6% | 42 973 |
EBITDA Million USD | Released Forecast Spread | 7 551 7 508 0.57% | 8 589 8 676 -1.01% | 10 005 9 767 2.43% | 9 473 9 494 -0.23% | 8 584 8 418 1.98% | 16 230 |
EBIT Million USD | Released Forecast Spread | 6 079 6 106 -0.44% | 7 265 7 503 -3.17% | 8 457 8 599 -1.65% | 7 950 8 164 -2.62% | 7 057 6 928 1.86% | 14 684 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 266 8 975 -41.33% | 7 230 7 041 2.68% | 6 156 7 148 -13.88% | 6 806 7 084 -3.93% | 6 555 6 311 3.86% | 13 749 |
Net income Million USD | Released Forecast Spread | 8 318 8 090 2.83% | 6 194 5 805 6.69% | 5 582 6 019 -7.27% | 6 245 6 102 2.35% | 5 240 5 307 -1.26% | 11 932 |
EPS USD | Released Forecast Spread | 8,89 8,65 2.83% | 6,79 6,36 6.69% | 6,12 6,43 -4.75% | 6,90 6,60 4.57% | 5,80 6,04 -3.92% | 13,4 |
Announcement Date | 30/01/20 | 29/01/21 | 03/02/22 | 02/02/23 | 06/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7 810 7 319 6.7% | 6 488 6 854 -5.33% | 6 942 6 901 0.58% | 7 302 7 376 -1% | 6 960 6 867 1.36% | 8 312 7 590 9.51% | 9 499 8 965 5.96% | 9 353 8 971 4.27% | 8 768 8 930 -1.81% | 10 000 | 11 327 | 12 781 | 10 920 | 12 135 |
EBITDA Million USD | Released Forecast Spread | 3 046 2 717 12.12% | 1 679 2 387 -29.67% | 2 373 2 385 -0.5% | 2 375 2 268 4.72% | 1 982 2 148 -7.73% | 2 618 2 416 8.39% | 986 3 460 -71.49% | 2 855 3 517 -18.81% | 3 049 2 827 7.84% | 3 750 | 4 844 | 5 994 | ||
EBIT Million USD | Released Forecast Spread | 2 610 2 336 11.74% | 1 330 1 790 -25.7% | 2 010 2 007 0.13% | 2 000 1 953 2.41% | 1 620 1 840 -11.95% | 2 252 2 078 8.37% | 575 921 -37.56% | 2 468 2 448 0.79% | 2 648 2 674 -0.96% | 3 078 | 3 976 | 4 812 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 089 2 107 -0.86% | 427 -399 207.07% | 2 509 1 248 101.03% | 2 536 2 455 3.3% | 3 000 | 3 878 | 4 497 | |||||||
Net income Million USD | Released Forecast Spread | 1 903 1 711 11.22% | 953 1 133 -15.93% | 1 452 1 453 -0.09% | 1 938 1 681 15.27% | 1 345 1 544 -12.9% | 1 763 1 660 6.22% | -57,4 -813 92.94% | 2 190 1 811 20.89% | 2 243 2 058 8.99% | 2 477 | 3 249 | 4 025 | ||
EPS USD | Released Forecast Spread | 1,05 1,85 -43.24% | 1,61 1,90 -15.26% | 2,14 1,78 20.22% | 1,49 2,04 -26.96% | 1,95 1,81 7.73% | -0,06 -0,66 90.91% | 2,42 2,26 7% | 2,48 2,44 1.64% | 2,77 | 3,60 | 4,46 | |||
Announcement Date | 28/04/22 | 04/08/22 | 01/11/22 | 02/02/23 | 27/04/23 | 08/08/23 | 02/11/23 | 06/02/24 | 30/04/24 | - | - | - | - | - |
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Eli Lilly and Company
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LLY Stock
- Stock
- Calendar Eli Lilly and Company